Targeted Restoration of the Intestinal Microbiota with a Simple, Defined Bacteriotherapy Resolves Relapsing Clostridium difficile Disease in Mice
Open accessThe DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Abstract
Relapsing C. difficile disease in humans is linked to a pathological imbalance within the intestinal microbiota, termed dysbiosis, which remains poorly understood. We show that mice infected with epidemic C. difficile (genotype 027/BI) develop highly contagious, chronic intestinal disease and persistent dysbiosis characterized by a distinct, simplified microbiota containing opportunistic pathogens and altered metabolite production. Chronic C. difficile 027/BI infection was refractory to vancomycin treatment leading to relapsing disease. In contrast, treatment of C. difficile 027/BI infected mice with feces from healthy mice rapidly restored a diverse, healthy microbiota and resolved C. difficile disease and contagiousness. We used this model to identify a simple mixture of six phylogenetically diverse intestinal bacteria, including novel species, which can re-establish a health-associated microbiota and clear C. difficile 027/BI infection from mice. Thus, targeting a dysbiotic microbiota with a defined mixture of phylogenetically diverse bacteria can trigger major shifts in the microbial community structure that displaces C. difficile and, as a result, resolves disease and contagiousness. Further, we demonstrate a rational approach to harness the therapeutic potential of health-associated microbial communities to treat C. difficile disease and potentially other forms of intestinal dysbiosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




![Figure 5 Whole genome (maximum likelihood) phylogeny of intestinal bacteria demonstrating the phylogenetic placement of disease-resolving bacteriotherapy bacteria (MixB) and the dominant members of the supershedder microbiota. Maximum likelihood phylogeny produced using FastTree from the concatenated protein sequence of 44 common genes (See methods). Species names marked in green indicate members of the suppressive MixB mixture, names marked in red indicate species that were commonly detected in the feces of supershedding mice, names in black are reference genomes from common intestinal bacteria that were included to provide phylogenetic context to the tree. Taxonomic designations are given at the relevant branch nodes. Adjacent pictures are transmission electron micrographs of sectioned bacterial strains that constitute MixB. Methods for sample processing and imaging have been described [33]. Scale bars are shown below bacteria.](https://figures.cochat.ai/paper-figures/d26cd52a622e48fbb6e5369ce372b754/targeted-restoration-of-the-intestinal-microbiota-with-a-simple-defined-figure-5.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Decrease in Lachnospiraceae has been associated with severe CDI suggesting a protective role for members of this family51”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [51]
Experimental — accuracy not yet measuredIn the citing paper
“Bacterial strains [54, 118, 119] and metabolites [54] associated with protection from C. difficile have now been identified”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [118]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
FastTree 2 – Approximately Maximum-Likelihood Trees for Large Alignments
Price, M. N., Dehal, P. S., & Arkin, A. P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009490 · Cited by 14,894
Velvet: Algorithms for de novo short read assembly using de Bruijn graphs
Zerbino, D. R., & Birney, E. (2008) · Genome Research · doi:10.1101/gr.074492.107 · Cited by 9,491
ARB: a software environment for sequence data
Ludwig, W. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh293 · Cited by 6,702
The Ribosomal Database Project: improved alignments and new tools for rRNA analysis
Cole, J. R., Wang, Q., Cardenas, E., Fish, J., Chai, B., Farris, R. J., Kulam-Syed-Mohideen, A. S., McGarrell, D. M., Marsh, T., Garrity, G. M., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn879 · Cited by 4,762
Interactive Tree Of Life (iTOL): an online tool for phylogenetic tree display and annotation
Letunic, I., & Bork, P. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btl529 · Cited by 3,299
Identifying bacterial genes and endosymbiont DNA with Glimmer
Delcher, A. L., Bratke, K. A., Powers, E. C., & Salzberg, S. L. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm009 · Cited by 3,134
Colonic Health: Fermentation and Short Chain Fatty Acids
Wong, J. M. W., de Souza, R., Kendall, C. W. C., Emam, A., & Jenkins, D. J. A. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200603000-00015 · Cited by 2,739
More powerful procedures for multiple significance testing
Hochberg, Y., & Benjamini, Y. (1990) · Statistics in Medicine · doi:10.1002/sim.4780090710 · Cited by 2,715 · cited 1×
“Adjusted p-values were calculated using the Benjamini and Hochberg method [57].”
MethodSchloss, P. D., & Handelsman, J. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.3.1501-1506.2005 · Cited by 2,501
Cited by
Items 401–500 of 539
Feces transplantation for recurrentClostridium difficileinfection: US experience and recommendations
Bakken, J. (2015) · Microbial Ecology in Health and Disease · doi:10.3402/mehd.v26.27657 · Cited by 8
Fecal Bacteriotherapy for Recurrent Clostridium difficile Infection: What’s Old Is New Again?
Suwantarat, N., & Bobak, D. A. (2013) · Current Infectious Disease Reports · doi:10.1007/s11908-013-0314-8 · Cited by 7
Lesniak, N. A., Tomkovich, S., Henry, A., Taylor, A., Colovas, J., Bishop, L., McBride, K., & Schloss, P. D. (2022) · mBio · doi:10.1128/mbio.01364-22 · Cited by 7
“Previous studies have identified reduced communities in a murine model using a homogeneous gut microbiota with a bottom-up approach (7, 19).”
BackgroundKenna, T., Hanson, A., Costello, M., & Brown, M. A. (2016) · Current Rheumatology Reports · doi:10.1007/s11926-016-0612-x · Cited by 7
The Human Microbiome in Health and Disease
Hill, C. J., Ross, R. P., Stanton, C., & O’Toole, P. W. (2016) · Wiley eBooks · doi:10.1002/9783527682386.ch4 · Cited by 7
Bollinger, K. W., Müh, U., Ocius, K. L., Apostolos, A. J., Pires, M. M., Helm, R. F., Popham, D. L., Weiss, D. S., & Ellermeier, C. D. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.14.584917 · Cited by 6
Bethlehem, L., Bartu, L., Marke, G., Mar, P., Feldman, S., Eggers, J., Ruprecht, C., Britton, G. J., Aggarwala, V., Bongers, G., et al. (2026) · Nature Medicine · doi:10.1038/s41591-026-04442-2 · Cited by 7
A Potential New Tool for Managing Clostridium difficile Infection
Armstrong, G. D., Pillai, D. R., Louie, T., MacDonald, J. A., & Beck, P. L. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit069 · Cited by 5
“in phylogenetic diversity of the GI microbiome and that this change is associated with clinical cure from CDI [30, 31].”
BackgroundTherapy of Clostridium difficile infection: perspectives on a changing paradigm
Tran, M.-C. N., Claros, M. C., & Goldstein, E. J. C. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.838218 · Cited by 5
The Pulmonary Microbiome, Mechanical Ventilation, and Trauma
Smith, A. D., Zhang, Y., & Shewale, S. (2012) · Biological Systems Open Access · doi:10.4172/2329-6577.1000116 · Cited by 5
“This technique is already likely to give way to more targeted bacteriotherapy approaches using a defined bacterial consortium [59].”
BackgroundBiodiversity–ecosystem function relationships on bodies and in buildings
Dunn, R. R., Reese, A. T., & Eisenhauer, N. (2018) · Nature Ecology & Evolution · doi:10.1038/s41559-018-0750-9 · Cited by 5
Variability and Stability of the Human Gut Microbiome
Flint, H. J. (2020) · Fascinating life sciences · doi:10.1007/978-3-030-43246-1_6 · Cited by 7
Predictive Values of Models of Clostridium difficile Infection
Chilton, C. H., & Freeman, J. (2015) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2014.11.011 · Cited by 5
Forward variable selection improves the power of random forest for high- dimensional microbiome dataPreprint
Dang, T., & Kishino, H. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.29.361360 · Cited by 5
“…known to play a principal role in the regulation of intestinal inflammatory processes [33] and intestinal barrier maintenance [34], and C. difficile infection was found to cause significant reductions in the Ruminococcaceae and/or Lachnospiraceae families that produce butyrate and SCFA [35] [36].”
BackgroundSahu, K. K., Yadav, K., Pradhan, M., Sharma, M. K., Dubey, A., Sucheta, & Kirubakaran, J. J. (2025) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2025.103659 · Cited by 5
Li, X., Xiao, F., Wang, X., Ye, L., Xiao, Y., Li, D., Zhang, T., & Wang, Y. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae506 · Cited by 9
“It may also play an important role in C difficile expansion [16, 32].”
BackgroundApproaches to common conditions of the gastrointestinal tract in pet hamsters
Baldrey, V. (2021) · Companion animal · doi:10.12968/coan.2020.0085 · Cited by 4
Moore, J. H., Salahi, A., Honrado, C., Warburton, C., Tate, S., Warren, C. A., & Swami, N. S. (2023) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.3c00192 · Cited by 4
Exploring ways to improve CDI outcomes
Galpérine, T., & Guery, B. P. (2018) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2017.10.009 · Cited by 4
Sommermeyer, H., Pituch, H. M., Wultańska, D., Wojtyła-Buciora, P., Piątek, J., & Bernatek, M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18115871 · Cited by 5
“Colonization of C. difficile to epithelial cells could be prevented by administering a mixture of Staphylococcus, Enterococcus, Lactobacillus, Anaerostipes, Bacteroidetes and Enterorhabdus [30].”
BackgroundDevelopment of an In Vitro Fermentation Model to Culture the Human Distal Gut Microbiota
McDonald, J. A. K. (2013) · The Atrium (University of Guelph) · Cited by 8
Seekatz, A. M., & Young, V. B. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.03.036 · Cited by 4
Emergence of antibiotic resistance in gut microbiota and its effect on human health
Kumar, M., Sharma, A., Verma, A., & Shrivastava, R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91313-3.00002-7 · Cited by 4
Cassir, N., Couturier, J., Delannoy, J., Wolfromm, A., Kassis, N., & Barbut, F. (2024) · Gut Microbes Reports · doi:10.1080/29933935.2024.2390926 · Cited by 6
Ansari, S., Purohit, K. J., Shelke, A. B., Shah, M., Nkhoma, I. A., Navale, A. M., & Wakchaure, R. S. (2026) · Antonie van Leeuwenhoek · doi:10.1007/s10482-026-02296-9 · Cited by 4
Type III Secretion System in Intestinal Pathogens and Metabolic Diseases
Zhou, L., Zhang, Y., Wu, S., Kuang, Y., Jiang, P., Zhu, X., & Yin, K. (2024) · Journal of Diabetes Research · doi:10.1155/2024/4864639 · Cited by 4
Cao, J. L., Meltzer, R. S., Cohn, E., Benjamin, A., Keskey, R. C., & Alverdy, J. C. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2552346 · Cited by 5
“Preclinical studies have supported this concept, as specific microbial consortia of symbiotic strains have been shown to successfully treat C. difficile as well as restore colonization resistance against vancomycin-resistant E. faecium in murine models 134,135 .”
Clostridium difficile infection and gut microbiota
Zalig, S., & Rupnik, M. (2014) · Seminars in Colon and Rectal Surgery · doi:10.1053/j.scrs.2014.05.005 · Cited by 3
Treating recurrent C. difficile infection—the challenge continues
Surawicz, C. M. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.240 · Cited by 3
FMT in Clostridium difficile and Other Potential Uses
Fine, S., & Kelly, C. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804024-9.00034-3 · Cited by 3
Probiotics and Prebiotics and the Gut Microbiota
Quigley, E. M. M. (2013) · CRC Press eBooks · doi:10.1201/b15561-13 · Cited by 5
Clindamycin-resistant Clostridioides difficile: a challenge in dentistry
Bernatek, M., Sommermeyer, H., Pituch, H. M., Wultańska, D., Kopczyński, Z., Piątek, J., & Wojtyła-Buciora, P. (2022) · Journal of Health Inequalities · doi:10.5114/jhi.2022.117343 · Cited by 4
Advances in Probiotics for Health and Nutrition
Zambare, V., Din, M. F. M., Gupta, P., & Prajapati, B. G. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.104299 · Cited by 6
Harnvoravongchai, P., Mattiello, S. P., Amabat, A., Jusail, C. P., Faisal, S. M., Kaushik, R. S., & Scaria, J. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.01842-25 · Cited by 2
“This outcome was unexpected, as additive inhibitory effects have been observed in multiple species combinations against enteric pathogens like Clostridium difficile (20, 40, 41).”
Fecal transplantation: clinical realities and prospects in the treatment of metabolic syndrome
Sas, E. I., Grinevich, V. B., & Barnakova, V. A. (2020) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-183-11-102-112 · Cited by 2
The Therapeutic Potential of the “Yin-Yang” Garden in Our Gut
Srikumar, S., & Fanning, S. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.80881 · Cited by 2
“[125] Lawley TD, Clare S, Walker AW, Stares MD, Connor TR, Raisen C, et al.”
BackgroundPreeclampsia de inicio temprano y tar dío: una antigua enfermedad, nuevas ideas
Paredes, R. O. L., & Romero, J. P. (2015) · Revista Peruana de Ginecología y Obstetricia · doi:10.31403/rpgo.v60i159 · Cited by 23
Future-Generation Sequencing and Clinical Microbiology
Kirkup, B. C., Mahlen, S. D., & Kallstrom, G. (2013) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2013.03.011 · Cited by 2
Pediatric Fecal Microbiota Transplantation
Mir, S. A. V., Kellermayer, R., & Gulati, A. (2014) · Current Pediatrics Reports · doi:10.1007/s40124-014-0049-5 · Cited by 2
Quorum Sensing Systems in Clostridia
Darkoh, C., & Ameyaw, G. A. (2014) · Springer eBooks · doi:10.1007/978-81-322-1982-8_13 · Cited by 3
The Human Microbiota and Pathogen Interactions
Walker, A. W. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397169-2.00019-6 · Cited by 3
Mutreja, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-420196-5.00008-3 · Cited by 2
The Microbiome: Current and Future view of an Ancient Paradigm
Neish, A. S., Pacifici, R., Mullé, J. G., Kraft, C. S., & Stephens, D. S. (2017) · Future Microbiology · doi:10.2217/fmb-2017-0083 · Cited by 2
Microbiome and Diseases: Pathogen Infection
Josenhans, C., & Graßl, G. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-90545-7_14 · Cited by 2
Methods in Computational Biology
Carlson, R. P., & Sauro, H. M. (2019) · MDPI eBooks · doi:10.3390/books978-3-03921-164-7 · Cited by 2
Translation of Immunomodulatory Effects of Probiotics into Clinical Practice
Ryan, J. C., Narasimha, S. V., Pattison, R., Zackria, R., Ghobrial, Y., Basit, S. A., Ammar, T. A. R. A., Jayaraman, V., Stone, C. D., & Shih, D. Q. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.109864 · Cited by 3
New concepts in C. difficile management
Mahida, Y. R. (2019) · British Medical Bulletin · doi:10.1093/bmb/ldz029 · Cited by 2
“Antibiotic-induced loss of colonization resistance has been reported to be re-established in mice using a mixture of 6 bacterial species (37), implying future prospect for the development of similar defined bacteriotherapy for patients with recurrent C.”
BackgroundWalk, S. T., Micić, D., Gałecki, A. T., Rogers, M. A. M., Washer, L., Newton, D. W., Malani, P., Young, V. B., & Aronoff, D. M. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit099 · Cited by 2
“to transmission [6]), the absolute risk to”
Bacterial, Viral, and Toxic Causes of Diarrhea, Gastroenteritis, and Anorectal Infections
Cohen, M. B. (2015) · Wiley eBooks · doi:10.1002/9781118512074.ch62 · Cited by 2
Jenior, M. L., Leslie, J. L., Young, V. B., & Schloss, P. D. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/211516 · Cited by 2
Microbiota Accessible Carbohydrates Suppress Clostridium difficile in a Murine ModelPreprint
Hryckowian, A. J., Treuren, W. V., Smits, S. A., Davis, N. M., Gardner, J. O., Bouley, D. M., & Sonnenburg, J. L. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/243253 · Cited by 3
(2013) · Environmental Microbiology Reports · doi:10.1111/1758-2229.12021 · Cited by 2
Gonzalez, X., & Irazoqui, J. E. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.02.565327 · Cited by 2
“Smaller reference communities (Lawley et al. , 2012; Kostic et al. , 2013; Brand et al. , 2015) and simpler model organisms can be of assistance in understanding such fundamental principles and the evolutionary forces at play.”
BackgroundBethlehem, L., Bartu, L., Marke, G., Mar, P., Feldman, S., Eggers, J., Ruprecht, C., Britton, G. J., Aggarwala, V., Bongers, G., et al. (2025) · medRxiv · doi:10.1101/2025.09.08.25335342 · Cited by 2
Wan, S., Yu, L., Jin, Y., Wang, R., Zhang, M., Shi, Q., Hu, H., Tai, Y., Luo, Y., Xu, Z., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-09059-8 · Cited by 1
Junior, D. M. D. S., Martins, G. C., Ferreira-Moura, T. A., Ordine, J. V. W., & Zaramela, L. S. (2025) · Future Microbiology · doi:10.1080/17460913.2025.2603859 · Cited by 1
What Is the Future for Therapies Derived from the Microbiome (Pharmabiotics)?
Rijkers, G. T., Mulder, L. H. C., Rombouts, F. M., & Akkermans, L. M. A. (2013) · World review of nutrition and dietetics · doi:10.1159/000346491 · Cited by 2
Comment traiter une infection digestive à Clostridium difficile en 2014 ?
Barbut, F., Guery, B. P., & Eckert, C. (2014) · Réanimation · doi:10.1007/s13546-014-0867-z · Cited by 2
Recent Update in Fecal Microbiota Transplantation
Kim, H., Kang, K., Kim, S.-J., & Im, E. (2014) · The Korean Journal of Microbiology · doi:10.7845/kjm.2014.4072 · Cited by 2
“질병과 관련된 이로운 미생물종의 분리는 새로운 치료법으로 연구되고 있다(Lawley et al., 2012).”
The microbiome in inflammatory bowel disease and beyond
Landy, J., & Hart, A. (2013) · Clinical Medicine · doi:10.7861/clinmedicine.13-6-s29 · Cited by 1
The role of the gut microbiome in host systems
Febinia, C. A., Ha, C. W. Y., Le, C., & Holmes, A. J. (2015) · Microbiology Australia · doi:10.1071/ma15005 · Cited by 1
FMT Happens: Regulating Fecal Microbiota Therapy in Canada; What You Need to Know
Salman, S., Vardatsikos, G., Avard, D. M., Palmour, N., Dewar, K., & Zawati, M. H. (2016) · World Medical & Health Policy · doi:10.1002/wmh3.174 · Cited by 1
Fecal Microbial Transplant: For Whom, How, and When
Kahn, S. A., & Kaplan, J. L. (2015) · Springer eBooks · doi:10.1007/978-3-319-17169-2_35 · Cited by 1
ADVANCES IN TRANSLATIONAL SCIENCE
Sellin, J. H., Murthy, S. K., Goetz, M., Hoffman, A. W., & Kießlich, R. (2012) · Cited by 1
Focus on gut microbiota in age-associated body changes
Agafonova, E. V. (2021) · Medical alphabet · doi:10.33667/2078-5631-2021-9-44-51 · Cited by 1
de Vos, W. M. (2014) · Apple Academic Press eBooks · doi:10.1201/b17254-20 · Cited by 1
Chen, H., Zhang, Y., Pan, Y., Wu, L., Wang, W., Zhang, H., & Lou, H. (2024) · BMC Microbiology · doi:10.1186/s12866-024-03313-5 · Cited by 2
Zhang, Y., Qi, X., Luo, F., Wang, G., & Ling, F. (2024) · Aquaculture · doi:10.1016/j.aquaculture.2024.741277 · Cited by 1
Voziki, A., Deda, O., & Kachrimanidou, M. (2024) · Metabolites · doi:10.3390/metabo14120677 · Cited by 1
Probiotics and Prebiotics in Immune System Protection
Nova, E., Abad, C., Gómez-Martínez, S., Pozo-Rubio, T., & Marcos, A. (2013) · CRC Press eBooks · doi:10.1201/b15561-14 · Cited by 3
Microbe-based approaches for the treatment of diabetes
Knip, M., & Siljander, H. (2015) · Diabetes Management · doi:10.2217/dmt.15.1 · Cited by 1
Gut Flora: In the Treatment of Disease
Bhardwaj, S. B. (2016) · InTech eBooks · doi:10.5772/65073 · Cited by 1
“Oral administration of a strain of Lactobacillus acidophilus (having phosphoglycerol transferase gene deleted) to APC floxed mice resulted in the reduction in polyps [16].”
BackgroundAntibiotic-Treated SPF Mice as a Gnotobiotic Model
Gancarčíková, S., Popper, M., Hrčková, G., Maďar, M., Mudroňová, D., Sopková, D., & Nemcová, R. (2018) · InTech eBooks · doi:10.5772/intechopen.71623 · Cited by 1
“[64, 65] and vancomycin [66] added to the drinking water.”
BackgroundCurrent Status of Clostridium Difficile Infection
Andoh, A., & Bamba, S. (2018) · Nihon Daicho Komonbyo Gakkai Zasshi · doi:10.3862/jcoloproctology.71.456 · Cited by 1
Chen, L. A. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz301 · Cited by 1
Dilution as a Solution: Targeting Microbial Populations with a Simplified Dilution Strategy
Bhattacharjee, D., & Seekatz, A. M. (2020) · mSphere · doi:10.1128/msphere.00701-20 · Cited by 1
Lung Microbiota and Its Impact on the Mucosal Immune Phenotype
Wu, B. G., & Segal, L. N. (2018) · ASM Press eBooks · doi:10.1128/9781555819705.ch7 · Cited by 3
The microbiota as target for therapeutic intervention in pediatric intestinal diseases
Vecchio, A. L., & Guarino, A. (2016) · Wiley eBooks · doi:10.1002/9781118982907.ch31 · Cited by 1
Probiotics enhance susceptibility of mice to cryptosporidiosisPreprint
Oliveira, B. C. M., & Widmer, G. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/304956 · Cited by 1
“experiments in mice aimed at testing the benefit of fecal transplant (12) and defined probiotics (13-15).”
BackgroundBrowne, H. (2018) · LSHTM Research Online (London School of Hygiene and Tropical Medicine) · doi:10.17037/pubs.04647551 · Cited by 4
Priority effects among amphibian microbes lead to varying levels of Bd infectionPreprint
Barnes, E. M., & Lewis, J. D. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.20.453099 · Cited by 1
“This is likely due in part to our limited knowledge on microbe-microbe and microbe-environment (itself a dynamic, living organism) interactions, or more specifically, how these come together historically to influence community function (Lawley et al. 2012, Fraune et al. 2015).”
BackgroundQuigley, E. M. M. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735070046.793569661 · Cited by 1
Evaluating patient susceptibility in Clostridium difficile infection
Islam, J. (2013) · University of Brighton Repository (University of Brighton)
Clostridium difficile infection: an Australian clinical perspective
Jenkin, G. (2015) · Microbiology Australia · doi:10.1071/ma15037
GUT in FOCUS Symposium NOBEL FORUM, Karolinska Institutet
(2015) · Microbial Ecology in Health and Disease · doi:10.3402/mehd.v26.28480
Clostridium difficile Infection Update for the Hospital-Based Physician
Pawlowski, S. W. (2014) · Current Emergency and Hospital Medicine Reports · doi:10.1007/s40138-014-0053-7
“This strain has been shown to have increased transmissibility, a 16- and 23-fold increase in toxin A and B production, respectively, enhanced sporulation, expression of a binary toxin, and increased resistance to antimicrobials and disinfectants [7, 19–23].”
BackgroundCounterinsurgency Doctrine Applied to Infectious DiseasePreprint
Kirkup, B. C. (2014) · doi:10.7287/peerj.preprints.236v1
“…became not only a PeerJ PrePrints | http://dx.doi.org/10.7287/peerj.preprints.236v1 | CC-BY 4.0 Open Access | received: 4 Feb 2014, published: 4 Feb 2014 P re P rin ts theoretical consideration but a reality (Srikanth and McCormick 2008, Lawley et al 2012, Britton and Young 2012, Ng et al 2013).”
BackgroundMethodInfluentialCurrent advances related to Clostridium difficile infection
Jang, B.-I., & Kim, Y. (2015) · The Indian Journal of Medical Research · doi:10.4103/0971-5916.155545
Schenck, L. P. (2014) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/25337
Novel therapeutic approaches targeting Clostridium difficile
Chen, C. (2014) · Digital Repository Service (Northeastern University) · doi:10.17760/d20004903
Smith, A. D. (2015) · Digital Commons @ UNT Health Science Center · Cited by 2
Fabisiak, A., Murawska, N., & Fichna, J. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1402516
Schroeter, K. (2014) · The Atrium (University of Guelph) · Cited by 2
Advances in Gastrointestinal Surgery
Chattopadhyay, T. K. (2015) · GI surgery annual · doi:10.1007/978-981-10-2010-0_10 · Cited by 1
The Role of the Gut Microbiota in Colonization Resistance against Clostridium difficile.
Schubert, A. M. (2015) · Deep Blue (University of Michigan)
Systems Immunology Approaches for Precision Medicine
Leber, A. J. (2017) · VTechWorks (Virginia Tech)
Role of intestinal dysbiosis on gut colonization by bacterial pathogens
Djuković, A. (2017) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/90415
Darmmikrobiom des Menschen: Status quo und Perspektiven
Clavel, T., & Hörmannsperger, G. (2017) · Pädiatrie up2date · doi:10.1055/s-0043-115278
“difficile durch ein bakterielles Konsortium [14, 88,89].”
BackgroundJenior, M. L. (2017) · Deep Blue (University of Michigan)
Xie, L., & Shou, W. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/264689
Metadata
- Authors
- Lawley, T. D., Clare, S., Walker, A. W., Stares, M. D., Connor, T. R., Raisen, C., Goulding, D., Rad, R., Schreiber, F., Brandt, C., Deakin, L. J., Pickard, D. J., Duncan, S. H., Flint, H. J., Clark, T. G., Parkhill, J., & Dougan, G.
- Affiliations
- Wellcome Sanger Institute (GB)
- University of Aberdeen (GB)
- London School of Hygiene & Tropical Medicine (GB)
- Corresponding author
- Lawley, Trevor D.
- ORCID
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-10-25
- Volume
- 8
- Issue
- 10
- Pages
- e1002995
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC3486913
- OpenAlex
- W2171605634
- Cited by
- 540
- References
- 73
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 19 · 2023: 20 · 2022: 24 · 2021: 33 · 2020: 21 · 2019: 37 · 2018: 47 · 2017: 42 · 2016: 71 · 2015: 65 · 2014: 73 · 2013: 61 · 2012: 6
- FWCI
- 45.27
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Aberdeen University Research Archive (Aberdeen University) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Wellcome Trust (076964, 098051)
- Medical Research Council (098051, 93614)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- Clostridium difficile infection, gut microbiota, dysbiosis, bacterial therapy, fecal microbiota transplantation, transmissibility, opportunistic pathogens, microbial metabolites, mouse model
- MeSH terms
- Animals, Enterocolitis, Pseudomembranous, Feces, Female, Intestines, Mice, Inbred C3H, Mice, Inbred C57BL, Molecular Sequence Data, Recurrence, Vancomycin, Clostridioides difficile, Probiotics, Drug Resistance, Bacterial, Mice, Microbial Interactions, Microbial Consortia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.